RankingsPricing
  1. JP-listed companies
  2. PhoenixBio Co.,Ltd.
  3. Financials
  4. Earnings per share

PhoenixBio Co.,Ltd.JP:6190

Market cap
¥2B
P/E ratio
18x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndEarnings per share (JPY)YoY (%)
Mar 31, 2025-111-1690.11%
Mar 31, 20247-95.19%
Mar 31, 2023145.2-223.60%
Mar 31, 2022-117.5+59.65%
Mar 31, 2021-73.6-48.11%
Mar 31, 2020-141.8+39.11%
Mar 31, 2019-102+9.21%
Mar 31, 2018-93.4-310.13%
Mar 31, 201744.4-9.91%
Mar 31, 201649.3+117.08%
Mar 31, 201522.7-55.99%
Mar 31, 201451.6-1874.23%
Mar 31, 2013-2.9-76.32%
Mar 31, 2012-12.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)